U.S. Point of Care Diagnostics Industry: Growth in Rapid Diagnostic Testing Solutions
Table of contents
As per Fortune Business Insights’ report, the U.S. point of care diagnostics Industry share sector attained a worth of USD 13.47 billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 7.9% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement by 2030, highlighting considerable opportunities within this flourishing high-volume industry. North America dominated the Industry in 2022.
Request a Free Sample PDF Brochure of U.S. Point of Care Diagnostics Industry: fortunebusinessinsights.com/enquiry/request..
In a recent study, Fortune Business Insights presents the nitty-gritty of the global U.S. Point of Care Diagnostics Industry considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities, and trends affecting Industry growth. Further, all the Industry shares associated with the Industry as well as the segments are expressed in terms of value and volume.
Top Companies in the U.S. Point of Care Diagnostics Industry:
F. Hoffmann-La Roche Ltd (Switzerland)
Thermo Fisher Scientific Inc. (U.S.)
Abbott Laboratories (U.S.)
Quest Diagnostics Incorporated (U.S.)
BD (U.S.)
bioMérieux SA (France)
Cardinal Health, Inc. (U.S.)
Cepheid (U.S.)
Trinity Biotech (Ireland)
Quidel Corporation (U.S.)
Bio-Rad Laboratories Inc. (U.S.)
The U.S. Point of Care Diagnostics Industry study outlines the key regions of North America, Latin America, Europe, East Asia, and Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each Industry player, including SWOT analysis, main Industry information, Industry share, revenue, pricing, and gross margin.
U.S. Point of Care Diagnostics Industry Dynamics:
Increased Demand for Rapid Testing: The U.S. point-of-care diagnostics Industry experiences growth due to increased demand for rapid and convenient testing solutions, driven by the need for timely diagnosis, treatment initiation, and disease management across various healthcare settings.
Expansion of Testing Capabilities: Point-of-care diagnostics continue to expand beyond traditional settings such as hospitals and clinics to include pharmacies, urgent care centers, and retail clinics, enhancing accessibility and convenience for patients while driving Industry growth.
Technological Advancements: Advances in technology, including miniaturization, automation, and integration with digital health platforms, are driving innovation in point-of-care diagnostic devices, enabling real-time testing, data connectivity, and remote monitoring capabilities, reshaping the Industry landscape.
Emphasis on Infectious Disease Testing: The U.S. point-of-care diagnostics Industry sees significant demand for rapid testing solutions for infectious diseases, including respiratory viruses, sexually transmitted infections, and emerging pathogens, fueled by public health concerns and the need for outbreak control measures.
Regulatory Landscape and Industry Access: Regulatory considerations, including FDA approvals, CLIA waivers, and reimbursement policies, play a critical role in Industry access and adoption of point-of-care diagnostic technologies, influencing product development, commercialization strategies, and competitive dynamics among industry players.
Speak to Analyst for Queries: fortunebusinessinsights.com/enquiry/speak-t..
The insights for each vendor consist of:
Company profile
SWOT analysis
Main Industry information
Industry share
Revenue, pricing, and gross margin
Crucial insights in the U.S. Point of Care Diagnostics Industry research:
Underlying macro- and microeconomic factors impacting the growth of the U.S. Point of Care Diagnostics Industry.
Basic overview of U.S. Point of Care Diagnostics Industry, including Industry definition, classification, and applications.
Scrutinization of each U.S. Point of Care Diagnostics Industry player based on mergers & acquisitions, R&D projects, and product launches.
Adoption trend of U.S. Point of Care Diagnostics Industry across various industries.
Important regions and countries offer lucrative opportunities to U.S. Point of Care Diagnostics Industry stakeholders.
Important regions covered in the U.S. Point of Care Diagnostics Industry report include:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Table of Contents:
Introduction
Research Scope
Customer Segmentation
Data Gathering Strategies
Key Definitions & Caveats
Executive Summary
Industry Dynamics
U.S. Point of Care Diagnostics Industry Drivers
U.S. Point of Care Diagnostics Industry Restraints
Industry Opportunities
Key Insights
Value Chain
Major M&A moves and game-changing partnerships.
Covid-19 Impact
Future of the Healthcare Industry
Competitive Landscape
Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
U.S. Point of Care Diagnostics Industry Growth Size 2024
Strategies Adopted by Leading Players
Company Profiles (Overview, Financials, Products and Services, and Recent Developments)
Disclaimer
TOC Continued…!
Order a copy of this research report at: fortunebusinessinsights.com/checkout-page/1..
FAQ’s
How big is the U.S. Point of Care Diagnostics Industry?
What factors are influencing the U.S. Point of Care Diagnostics Industry growth in North America?
Who are the key U.S. Point of Care Diagnostics Industry players?
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic Industry intelligence, giving a granular overview of the Industry they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use market-leading research tools and techniques to compile comprehensive Industry studies interspersed with relevant data.
At Fortune Business Insights, we aim to highlight our clients' most lucrative growth opportunities. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA:+1 424 253 0390,
United Kingdom: +44 2071 939123,
APAC: +91 744 740 1245